XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
112 hedge funds and large institutions have $521M invested in Intersect ENT, Inc in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.
Holders
112
Holders Change
–
Holders Change %
0%
% of All Funds
2.46%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
20
Increased
44
Reduced
33
Closed
20
Calls
$16.1M
Puts
$3.05M
Net Calls
+$13.1M
Net Calls Change
+$2.12M
Top Buyers
1 |
1
UBS Group
Zurich,
Switzerland
|
$23.6M |
2 |
BC
2
Broadfin Capital
New York
|
$13.3M |
3 |
FLAM
3
First Light Asset Management
Edina,
Minnesota
|
$20.7M |
4 |
![]()
4
Adage Capital Partners
Boston,
Massachusetts
|
$15.3M |
5 |
PVI
5
Pura Vida Investments
New York
|
$11.4M |